|
|
|
|
 |
Corporate Profile
Æterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a global biopharmaceutical company focused on endrocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization.
Contact us:
Æterna Zentaris Inc.
1405 du Parc-Technologique Blvd.
Québec, Québec
Canada
G1P 4P5
Phone: (418) 652-8525
Fax: (418) 652-0881
www.aezsinc.com
|
 |
|
|
Æterna Zentaris Reports Third Quarter 2008 Financial and Operating Results more...>
Æterna Zentaris Agrees to Sell Cetrotide® Royalty Stream for
$52.5 Million to Cowen Healthcare Royalty Partners more...>
Æterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008 more...>
|
 |
|
November 12, 2008
3rd Quarter 08 Financial Results
More |
|
|
Download PDF (67K) |
| Download and install Acrobat Reader 6.0. |
|
|
|
